Welcome to #1 DIGITAL HEALTH NEWS Portal

AI Predicts Enzyme Function Better than Leading Tools

A new artificial intelligence (AI) tool can predict the functions of enzymes based on their amino acid sequences, even when the enzymes are unstudied or poorly understood. The researchers said the AI tool, dubbed CLEAN, outperforms the leading state-of-the-art tools in accuracy, reliability and sensitivity. Better understanding of enzymes and their functions would be a boon for research in genomics, chemistry, industrial materials, medicine, pharmaceuticals and more.

Read more ...

Machine Learning Models Rank Predictive Risks for Alzheimer's Disease

Once adults reach age 65, the threshold age for the onset of Alzheimer's disease, the extent of their genetic risk may outweigh age as a predictor of whether they will develop the fatal brain disorder, a new study suggests.

The study, published recently in the journal Scientific Reports, is the first to construct machine learning models with genetic risk scores, non-genetic information and electronic health record data from nearly half a million individuals to rank risk factors in order of how strong their association is with eventual development of Alzheimer's disease.

Read more ...

Philips Virtual Care Management Offers a Comprehensive Approach to Telehealth for Patients, Providers and Payers

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the debut of Philips Virtual Care Management, a comprehensive portfolio of flexible solutions and services to help health systems, providers, payers and employer groups more meaningfully motivate and deeply connect with patients from virtually anywhere.

Read more ...

Machine Learning Combines with Multispectral Infrared Imaging to Guide Cancer Surgery

Surgical tumor removal remains one of the most common procedures during cancer treatment, with about 45 percent of cancer patients undergoing surgical tumor removal at some point. Thanks to recent progress in imaging and biochemical technologies, surgeons are now better able to tell tumors apart from healthy tissue. Specifically, this is enabled by a technique called "fluorescence-guided surgery" (FGS).

Read more ...

JNM Explores Potential Applications for ChatGPT in Nuclear Medicine and Molecular Imaging

A new article in The Journal of Nuclear Medicine explores the potential for using ChatGPT, an artificial intelligence chatbot, in the field of nuclear medicine and molecular imaging. In the article, Irène Buvat, PhD, and Wolfgang Weber, MD, PhD, report on discussions they held with ChatGPT regarding several nuclear medicine and molecular imaging topics and provide their commentary on the pros and cons of using the chatbot.

Read more ...

Paper Written Using ChatGPT Demonstrates Opportunities and Challenges of AI in Academia

ChatGPT has the potential to create increasing and exciting opportunities - but also poses significant challenges - for the academic community, according to an innovative study written in large part using the software.

Launched in November 2022, ChatGPT is the latest chatbot and artificial intelligence (AI) platform touted as having the potential to revolutionise research and education.

Read more ...

AI Predicts Genetics of Cancerous Brain Tumors in under 90 Seconds

Using artificial intelligence (AI), researchers have discovered how to screen for genetic mutations in cancerous brain tumors in under 90 seconds - and possibly streamline the diagnosis and treatment of gliomas, a study suggests.

A team of neurosurgeons and engineers at Michigan Medicine, in collaboration with investigators from New York University, University of California, San Francisco and others, developed an AI-based diagnostic screening system called DeepGlioma that uses rapid imaging to analyze tumor specimens taken during an operation and detect genetic mutations more rapidly.

Read more ...

Insilico Medicine Brings AI-Powered "ChatPandaGPT" to its Target Discovery Platform

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform. The new feature, "ChatPandaGPT," enables researchers to have natural language conversations with the platform and efficiently navigate and analyze large datasets, facilitating the discovery of potential therapeutic targets and biomarkers in a more efficient manner.

Read more ...

BlueRock Therapeutics to Incorporate Wearable and Invisible Contactless Digital Health Technologies from Rune Labs and Emerald Innovations in Parkinson's Disease Clinical Trial

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned, independently operated subsidiary of Bayer AG, announced a collaboration with Rune Labs and Emerald Innovations focused on using wearable and invisible contactless digital health technology to improve monitoring and data collection for Parkinson's disease clinical trials.

Read more ...

Hospital Future Act, AI, Consumer Health - Numerous Aspects of Digital Health at DMEA 2023

25 - 27 April 2023, Berlin, Germany.
The congress programme at DMEA 2023 has been announced: over the three days of the event more than 200 speakers from all over the world will present their visions of digitalisation in the healthcare system. Among those taking part will be Federal Health Minister Prof. Dr. Karl Lauterbach, Dr. Susanne Ozegowski and Dr. med. Markus Leyck Dieken.

Read more ...